Mural Oncology plc MURA
2.04 USD 0.00 (+0.00%)
Dec 9, 2025, 9:30 AM EST
2.04 Day range 2.04
52-week range unavailable
- YTD
- -36.65%
- 1 year
- -48.87%
Analyst view
Price target (mean) 16.33 +700.7% upside
Now 2.04
- Target (low)
- 13.00
- Target (mean)
- 16.33
- Target (high)
- 18.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.98 | -2.03 – -1.95 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Next quarter | -1.96 | -2.05 – -1.86 | -1.84 | -6.3% | 0 | 0.0% | 2 |
| Current year | -7.54 | -7.59 – -7.51 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Next year | -4.72 | -5.32 – -3.90 | -7.54 | +37.5% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 17, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 4, 2024 | Raymond James | Initiated | — | Strong Buy |
| Jun 28, 2024 | Rodman & Renshaw | Initiated | — | Buy |
| Apr 4, 2024 | Morgan Stanley | Initiated | — | Overweight |